Recombinant Factor VIIa (Savara)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Factor VIIa (Savara)
Drug Alias NameFactor VIIa Therapy (Savara)Recombinant Factor VIIa (SerendeX)Factor VIIa Therapy (Serendex ApS)Recombinant Factor VIIa Therapy (Serendex)Recombinant Factor VIIa Therapy (Savara)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsHemorrhageLung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSerendex Pharmaceuticals AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSavara IncSerendex Pharmaceuticals AS
Active IndicationsN/A
Inactive IndicationsHemorrhageLung Injury

Other Information

ATC CodeN/A
Related LinksN/A